E-LIB Suche - Ergebnisse für: Breyer

1

Loss of membranous NECTIN-4 occurs frequently during metast..:

Klümper, N. ; Ralser, D.J. ; Ellinger, J....
European Urology. 83 (2023) - p. S772-S773 , 2023

Link: https://doi.org/10.1016/..

2

Intrinsic molecular urothelial cancer subtypes remain stabl..:

Cox, A. ; Klümper, N. ; Stein, J....
European Urology. 83 (2023) - p. S1690-S1691 , 2023

Link: https://doi.org/10.1016/..

3

Spatial immunephenotypes of distant metastases but not matc..:

Erlmeier, F. ; Klümper, N. ; Landgraf, L....
European Urology. 83 (2023) - p. S1686-S1687 , 2023

Link: https://doi.org/10.1016/..

4

Prognosis of primary papillary Ta-G3 bladder cancer in the ..:

Beijert, I.J. ; Hentschel, A.E. ; Bründl, J....
European Urology Open Science. 45 (2022) - p. S48-S50 , 2022

Link: https://doi.org/10.1016/..

5

Tumor budding correlates with discohesive growth pattern, t..:

Eckstein, M. ; Kimmel, C. ; Bruendl, J....
European Urology. 79 (2021) - p. S620 , 2021

Link: https://doi.org/10.1016/..

6

Bladder tumor subtype commitment occurs in carcinoma in-sit..:

Wullweber, A. ; Strick, R. ; Lange, F....
European Urology. 79 (2021) - p. S640 , 2021

Link: https://doi.org/10.1016/..

7

The HELENA study: Hexvix®-TURB vs. white-light TURB followe..:

Gierth, M. ; Breyer, J. ; Zeman, F....
World Journal of Urology. 39 (2021) 10 - p. 3799-3805 , 2021

Link: https://doi.org/10.1007/..

8

Divergent immunobiological correlates of FDA-/EMA-approved ..:

Weyerer, V ; Geppert, CI ; Bertz, S...
Urologic Oncology: Seminars and Original Investigations. 38 (2020) 12 - p. 908 , 2020

Link: https://doi.org/10.1016/..

9

Prognostic role of FGFR alterations and FGFR mRNA expressio..:

Roghmann, F. ; Wirtz, R. ; Santiago-Walker, A....
European Urology Open Science. 19 (2020) - p. e830 , 2020

Link: https://doi.org/10.1016/..

10

Epidemiology and therapy of lymphoceles after robot-assiste..:

Gossler, C. ; Hillinger, J.M. ; Bruendl, J....
European Urology Open Science. 19 (2020) - p. e2112 , 2020

Link: https://doi.org/10.1016/..

11

Androgen receptor mRNA expression in urothelial carcinoma o..:

Sikic, D. ; Wirtz, R.M. ; Wach, S....
European Urology Supplements. 18 (2019) 1 - p. e317 , 2019

Link: https://doi.org/10.1016/..

12

Performance of FDA/EMA approved PD-L1 assays in urothelial ..:

Eckstein, M. ; Erben, P. ; Kriegmair, M....
European Urology Supplements. 18 (2019) 1 - p. e308-e309 , 2019

Link: https://doi.org/10.1016/..

13

Papillary urothelial neoplasm of low malignant potential (P..:

Hentschel, A.E. ; Van Rhijn, B.W.G. ; Bründl, J....
European Urology Supplements. 18 (2019) 11 - p. e3559-e3561 , 2019

Link: https://doi.org/10.1016/..

14

Tumor immune microenvironment drives prognostic relevance c..:

Strissel, P. ; Pfannstiel, C. ; Chiappinelli, K....
European Urology Supplements. 18 (2019) 1 - p. e1455-e1456 , 2019

Link: https://doi.org/10.1016/..

15

Loss of CHEK2 is associated with risk of progression and wo..:

Spachmann, P.J. ; Azzolina, V. ; Weber, F....
European Urology Supplements. 18 (2019) 1 - p. e1635 , 2019

Link: https://doi.org/10.1016/..